Patents Assigned to Antares Pharma, Inc.
  • Publication number: 20250114297
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 16, 2024
    Publication date: April 10, 2025
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Publication number: 20250050025
    Abstract: An exemplary embodiment of an injector includes a trigger mechanism, an energy source, and a user-operable firing-initiation member. The trigger mechanism can include a floating trigger member having a retaining portion, a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a floating trigger engagement member configured to engage the retaining portion of the floating trigger member when the floating trigger member is in a pre-firing condition. The energy source can be associated with the ram for powering the ram to expel the medicament, and the user-operable firing-initiation member can be operable for causing an axial rotation of the floating trigger member from the pre-firing condition to a firing condition in which the floating trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 13, 2025
    Applicant: Antares Pharma, Inc.
    Inventors: Thomas Kramer, Matthew H. Rust, Paul M. Goudreau, Peter A. Hoeft, Julius C. Sund, Peter L. Sadowski, Michael Travanty, Patrick Madsen
  • Publication number: 20250050024
    Abstract: An injector includes a trigger mechanism including: a trigger member disposed about an axis having an aperture and a protrusion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a trigger engagement member configured to engage the aperture of the trigger member when the trigger member is in a pre-firing condition; an energy source associated with the ram for powering the ram to expel the medicament; and a user-operable firing-initiation member having an aperture engaged with the protrusion of the trigger member and operable for causing an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 13, 2025
    Applicant: Antares Pharma, Inc.
    Inventor: Michael TRAVANTY
  • Publication number: 20250050037
    Abstract: An injection device, for example, an auto-injector of any type, includes a sleeve configured to hold a medicament chamber. The sleeve may be sufficiently deformable such that it functions as a shock absorbing member to distribute the force exerted on the medicament chamber during use of the injection device.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 13, 2025
    Applicant: Antares Pharma, Inc.
    Inventors: John Pierre MEHAWEJ, Michael TRAVANTY
  • Patent number: 12220560
    Abstract: An exemplary embodiment of an injector includes a trigger mechanism, an energy source, and a user-operable firing-initiation member. The trigger mechanism can include a floating trigger member having a retaining portion, a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a floating trigger engagement member configured to engage the retaining portion of the floating trigger member when the floating trigger member is in a pre-firing condition. The energy source can be associated with the ram for powering the ram to expel the medicament, and the user-operable firing-initiation member can be operable for causing an axial rotation of the floating trigger member from the pre-firing condition to a firing condition in which the floating trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: February 11, 2025
    Assignee: Antares Pharma, Inc.
    Inventors: Thomas Kramer, Matthew H. Rust, Paul M. Goudreau, Peter A Hoeft, Julius C. Sund, Peter L. Sadowski, Michael Travanty, Patrick Madsen
  • Publication number: 20250041522
    Abstract: An exemplary embodiment of injector includes a trigger mechanism, an energy source, and a user-operable firing-initiation member. The trigger member can include a trigger member having a retainer portion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom and a trigger engagement member configured to engage the retainer portion of the trigger member in a pre-firing condition. The energy source can be associated with the ram for powering the ram to expel the medicament, and the user-operable firing-initiation member can be operable for causing an axial rotation between the trigger engagement member and the retainer portion from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retainer portion to allow the energy source to fire the ram.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 6, 2025
    Applicant: Antares Pharma, Inc.
    Inventors: Thomas Kramer, Matthew H. Rust, Paul M. Goudreau, Peter A. Hoeft, Julius C. Sund, Peter L. Sadowski
  • Publication number: 20250041537
    Abstract: An exemplary embodiment of the present disclosure can provide an injector including a trigger mechanism, an energy source, and a user-operable firing-initiation member. The trigger member can include a trigger member having a retainer portion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom and a trigger engagement member configured to engage the retainer portion of the trigger member in a pre-firing condition. The energy source can be associated with the ram for powering the ram to expel the medicament, and the user-operable firing-initiation member can be operable for causing an axial rotation between the trigger engagement member and the retainer portion from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retainer portion to allow the energy source to fire the ram.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 6, 2025
    Applicant: Antares Pharma, Inc.
    Inventors: Thomas E. Kramer, Matthew H. Rust, Paul M. Goudreau, Peter A. Hoeft, Julius C. Sund, Peter L. Sadowski
  • Publication number: 20250032509
    Abstract: Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.
    Type: Application
    Filed: September 25, 2024
    Publication date: January 30, 2025
    Applicant: Antares Pharma, Inc.
    Inventor: Shaowei ONG
  • Patent number: 12179007
    Abstract: An exemplary embodiment of the present disclosure can provide an injector including a trigger mechanism, an energy source, and a user-operable firing-initiation member. The trigger member can include a trigger member having a retainer portion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom and a trigger engagement member configured to engage the retainer portion of the trigger member in a pre-firing condition. The energy source can be associated with the ram for powering the ram to expel the medicament, and the user-operable firing-initiation member can be operable for causing an axial rotation between the trigger engagement member and the retainer portion from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retainer portion to allow the energy source to fire the ram.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: December 31, 2024
    Assignee: Antares Pharma, Inc.
    Inventors: Thomas E. Kramer, Matthew H. Rust, Paul M. Goudreau, Peter A. Hoeft, Julius C. Sund, Peter L. Sadowski
  • Patent number: 12171986
    Abstract: An exemplary embodiment of injector includes a trigger mechanism, an energy source, and a user-operable firing-initiation member. The trigger member can include a trigger member having a retainer portion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom and a trigger engagement member configured to engage the retainer portion of the trigger member in a pre-firing condition. The energy source can be associated with the ram for powering the ram to expel the medicament, and the user-operable firing-initiation member can be operable for causing an axial rotation between the trigger engagement member and the retainer portion from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retainer portion to allow the energy source to fire the ram.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: December 24, 2024
    Assignee: Antares Pharma, Inc.
    Inventors: Thomas Kramer, Matthew H. Rust, Paul M. Goudreau, Peter A. Hoeft, Julius C. Sund, Peter L. Sadowski
  • Patent number: 12144817
    Abstract: Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: November 19, 2024
    Assignee: Antares Pharma, Inc.
    Inventor: Shaowei Ong
  • Patent number: 12121704
    Abstract: An injector for injecting a medicament in a patient. The injector includes a container comprising a fluid chamber containing a first volume of a medicament, and an injection conduit associated with the fluid chamber for defining a fluid pathway therefrom to inject the medicament from the fluid chamber through the injection conduit to an injection location. The injector also includes a firing mechanism associated with the fluid chamber for expelling the medicament from the fluid chamber through the injection conduit, arid a volume-control mechanism operable to control a fraction of the first volume of medicament that is injected when the firing mechanism is actuated to inject the medicament.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: October 22, 2024
    Assignee: Antares Pharma, Inc.
    Inventors: Paul R. Lesch, Matthew H. Rust, Thomas E. Kramer
  • Patent number: 12102643
    Abstract: The present disclosure provides aqueous formulations comprising hydrocortisone sodium phosphate and monothioglycerol. In some embodiments, the formulations comprise monobasic sodium phosphate, dibasic sodium phosphate, or disodium EDTA. The present disclosure further provides a method of treating a disease or disorder in a subject by administering the aqueous formulation.
    Type: Grant
    Filed: March 24, 2023
    Date of Patent: October 1, 2024
    Assignee: Antares Pharma, Inc.
    Inventors: Xiaoming Chen, Shaowei Ong
  • Publication number: 20240238311
    Abstract: The present disclosure provides aqueous formulations comprising hydrocortisone sodium phosphate and monothioglycerol. In some embodiments, the formulations comprise monobasic sodium phosphate, dibasic sodium phosphate, or disodium EDTA. The present disclosure further provides a method of treating a disease or disorder in a subject by administering the aqueous formulation.
    Type: Application
    Filed: March 20, 2024
    Publication date: July 18, 2024
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming Chen, Shaowei Ong
  • Publication number: 20240131035
    Abstract: Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.
    Type: Application
    Filed: October 27, 2023
    Publication date: April 25, 2024
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming CHEN, Shaowei ONG
  • Publication number: 20240131275
    Abstract: An injection device for injecting medicament in a patient includes a syringe coupled to a housing and radially retained by a retaining rib. A needle guard is slideably coupled to the housing and spring biased in a distal direction by a return spring. A ram is slideably coupled to the housing and spring biased in the distal direction by a main spring. An initial position is defined by a retaining arm being disposed in the longitudinal path of the ram preventing firing. A released position is defined by the retaining arm being clear from the longitudinal path of the ram allowing the ram to extend distally. A locked position is defined by the retaining arm being disposed in the longitudinal path of the ram and a lock arm of the ram being disposed in the longitudinal path of the needle guard preventing the needle guard from being retracted.
    Type: Application
    Filed: December 11, 2023
    Publication date: April 25, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: John Pierre Mehawej, Bryan James Sarkinen
  • Publication number: 20240091239
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 21, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Publication number: 20240075209
    Abstract: In one embodiment there is an injector comprising a housing having a proximal end and a distal end, a shell, a plunger, a needle guard, a first member, and an actuation assembly. The shell may be within the housing and may have a cavity to receive at least a portion of a medicament chamber. The shell may be moveable with respect to the housing from an initial position to an injecting position. The plunger may be moveable with respect to the shell. The needle guard may be moveable between an extended position and a retracted position. The first member may be within the housing. The actuation assembly may be coupled to the housing and the shell. The needle guard may move the first member with respect to the housing as the needle guard moves from the extended position to the retracted position. The actuation assembly may move the shell from the initial position to the injecting position when the first member moves with respect to the housing.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 7, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: Kevin Swanson, Aaron V. Hua
  • Publication number: 20240024582
    Abstract: An injector includes a trigger mechanism including: a trigger member disposed about an axis having an aperture and a protrusion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a trigger engagement member configured to engage the aperture of the trigger member when the trigger member is in a pre-firing condition; an energy source associated with the ram for powering the ram to expel the medicament; and a user-operable firing-initiation member having an aperture engaged with the protrusion of the trigger member and operable for causing an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
    Type: Application
    Filed: October 4, 2023
    Publication date: January 25, 2024
    Applicant: Antares Pharma, Inc.
    Inventor: Michael Travanty
  • Patent number: 11878156
    Abstract: An injection device for injecting medicament in a patient includes a syringe coupled to a housing and radially retained by a retaining rib. A needle guard is slideably coupled to the housing and spring biased in a distal direction by a return spring. A ram is slideably coupled to the housing and spring biased in the distal direction by a main spring. An initial position is defined by a retaining arm being disposed in the longitudinal path of the ram preventing firing. A released position is defined by the retaining arm being clear from the longitudinal path of the ram allowing the ram to extend distally. A locked position is defined by the retaining arm being disposed in the longitudinal path of the ram and a lock arm of the ram being disposed in the longitudinal path of the needle guard preventing the needle guard from being retracted.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: January 23, 2024
    Assignee: ANTARES PHARMA, INC.
    Inventors: John Pierre Mehawej, Bryan James Sarkinen